Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000742

Drug Information
NameClomipramine    
SynonymsHydiphen; IDI1_000797; BIDD:PXR0151; AKOS001487687; Lopac0_000307; NCGC00015264-03; Clomipramina [INN-Spanish]; LS-60386; 3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine; Spectrum3_001707; Tocris-0457; NCGC00024355-05; Prestwick1_000269; Monochlorimipramine; 5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-; KBioGR_000759; SPBio_001778; Clomipraminum; KBio2_003492; CHEBI:47780; BRN 1323477; 3-Chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; KBioSS_000924; NSC169865; STOCK2S-26559; NCGC00024355-04; Clomipramine (INN); DivK1c_000797; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine; BSPBio_000118; NINDS_000797; 17321-77-6 (mono-hydrochloride); 5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-; KBio1_000797; Spectrum4_000350; 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine; 5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro- (8CI); D07727; C14H12ClN.C6H15N; UNII-NUV44L116D; Spectrum_000444; WLN: T C676 BN & T & J B3N1 & 1 EG; Prestwick2_000269; L000890; 5H-Dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-; NCGC00015264-09; 3-Chloroimipramine; NSC 169865; PDSP2_000240; Spectrum2_001729; Prestwick3_000269; Clomicalm; KBio3_002514; Lopac-C-7291; 83162-38-3; Clomipraminum [INN-Latin]; CHEBI:100996; NCGC00015264-01; BRD-K52989797-003-05-8; KBio2_000924; NCGC00024355-02; PDSP1_000241; Anafranil base; clomipramine; CHEMBL415; DB01242; Clomipramine [INN:BAN]; Anafranil (TN); 5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-; NCGC00015264-02; Clomipramina; 303-49-1; G 34586; 5-20-08-00103 (Beilstein Handbook Reference); EINECS 206-144-2; KBio2_006060; SPBio_002337; STK534842; 3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine; AB00053695; 5H-Dibenz[b,f]azepine, 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-; Prestwick0_000269; CAS-17321-77-6; Biomol-NT_000151; Oprea1_312582; BRD-K52989797-001-01-1; Chlomipramine; BSPBio_003294; CID2801; AC1L1EHZ; DB07600; Spectrum5_001235; BPBio1_000130; 5H-Dibenz[b,f]azepine, 10,11-dihydro-3-chloro-5-[3-(dimethylamino)propyl]-; 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine; C06918; BPBio1_000661; MolPort-002-051-949; Anafranil (free base); Chlorimipramine    
Trade NameAnafranil    
CompanyNorvatis Phamaceuticals Corporation    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntidepressive Agents    
CAS NumberCAS 303-49-1
FormularC19H23ClN2    
PubChem Compound IDCID 2801.    
PubChem Substance IDSID 9135.    
ChEBI47780;    
SuperDrug ATC IDN06AA04;    
SuperDrug CAS ID000303491;    
TargetSerotonin re-uptakeInhibitor[2]
Ref 1Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. To Reference
Ref 2Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review. J Am Acad Nurse Pract. 2009 Apr;21(4):207-13. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543